Novo Nordisk A/S (NVO) |
|
52.615 0.795 (1.53%)
|
08-22 11:57 |
|
Open: |
52.67 |
Pre. Close: |
51.82 |
|
High:
|
52.75 |
Low:
|
52.5 |
|
Volume:
|
783,026 |
Market Cap:
|
124449M |
|
|
|
Stock Price Prediction |
Update at 5:00pm EST |
|
If tomorrow:
|
Open lower
|
Open higher
|
|
High:
|
52.164 - 52.358 |
52.358 - 52.513 |
|
Low:
|
51.219 - 51.466 |
51.466 - 51.666 |
|
Close:
|
51.452 - 51.83 |
51.83 - 52.135 |
|
Technical analysis |
as of: 2019-08-22 11:29:10 AM |
|
Overall:
|
 |
| Stoxline posted a BUY today, same as yesterday. Upward movement continues. |
| Target: |
Six months: 61.61  One year: 71.96 |
| Support: |
Support1: 49.55 Support2: 47.57 |
| Resistance: |
Resistance1: 52.75 Resistance2: 61.61 |
| Pivot: |
50.52 |
| Moving Average: |
MA(5): 51.72 MA(20): 50.03
MA(100): 49.52 MA(250): 48.04 |
| MACD: |
MACD(12,26): 0.70 Signal(9): 0.41 |
| Stochastic oscillator: |
%K(14,3): 90.68 %D(3): 86.28 |
| RSI: |
RSI(14): 64.50 |
| 52-week: |
High: 52.83 Low: 41.23 Change(%): 7.5 |
| Average Vol(K): |
3-Month: 150362 10-Days: 133580 |
|
Price, moving averages and Bollinger Bands |
|
Price and moving averages has closed above its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BULLISH in short-term; and BULLISH in mid-long term.NVO has closed below upper band by 8.4%. Bollinger Bands are 36.3% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices. |
|
|
Headline News |
Mon, 19 Aug 2019 17:11:41 Z
The Zacks Analyst Blog Highlights: Cisco, Medtronic, Novo Nordisk, Southern and TransDigm
Sun, 18 Aug 2019 23:07:52 Z
Validea's Top Five Healthcare Stocks Based On Warren Buffett - 8/18/2019
Fri, 16 Aug 2019 21:12:06 Z
Top Stock Reports for Cisco, Medtronic & Novo Nordisk
Thu, 15 Aug 2019 23:08:55 Z
Novo Nordisk Waits for Its Next Launch
Thu, 15 Aug 2019 13:18:45 Z
Novo Nordisk A/S (NVO) Ex-Dividend Date Scheduled for August 16, 2019
|
Financial Analysis |
| Growth |
|
| Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing. |
| Profitability |
 |
| Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs. |
| Solvency |
|
| Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry. |
| Efficiency |
 |
| Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not. |
| Click here to get more fundamental analysis.
|
|
|
|
|
|
|
| Free Technical Analysis Charts
|
|
|
Stock Basics & Statistics |
| Sector: Healthcare |
| Industry: Biotechnology |
| Shares Out. (M) |
2440.00 |
| Shares Float (M) |
1690.00 |
|
% Held by Insiders
|
0.02 |
|
% Held by Institutions
|
9.41 |
|
Shares Short (K)
|
2790 |
|
Shares Short P. Month (K)
|
|
Stock Financials |
|
EPS
|
2.460 |
|
EPS Est. Current Year
|
2.420 |
|
EPS Est. Next Year
|
2.590 |
|
EPS Est. Next Quarter
|
0.530 |
|
Forward EPS
|
2.780 |
|
Book Value (p.s.)
|
3.080 |
|
PEG Ratio
|
2.03 |
|
Profit Margin
|
32.16 |
|
Operating Margin
|
|
|
Return on Assets (ttm)
|
28.4 |
|
Return on Equity (ttm)
|
73.6 |
|
Qtrly Rev. Growth
|
9.6 |
|
Gross Profit (p.s.)
|
38.611 |
|
Sales Per Share
|
|
|
EBITDA (p.s.)
|
|
|
Qtrly Earnings Growth
|
-7.20 |
|
Operating Cash Flow (M)
|
|
|
Levered Free Cash Flow (M)
|
|
Stock Valuations |
|
P/E
|
21.40 |
|
P/E Growth Ratio
|
0.02 |
|
P/BV
|
17.09 |
|
P/S
|
|
|
P/CF
|
|
Dividends & Splits |
|
Dividend
|
1.230 |
|
Dividend Yield
|
0.02 |
|
Dividend Pay Date
|
2019-09-27 |
|
Ex-Dividend Date
|
2019-03-22 |
|
Forward Dividend
|
1.250 |
|
Last Split Date
|
2014-01-09 |
|
Last Split Ratio
|
-1e+010 |
|
7 Binary Options
|
|
Your Ad Here
|
|
